Regina E Groves's Net Worth

$1.7 Million

Estimate Recalculated Nov 7, 2024 04:46PM EST

Who is Regina E Groves

Regina E Groves has an estimated net worth of $1.7 Million. This is based on reported shares across multiple companies, which include AtriCure, Inc., REVA Medical, Inc., and Fulgent Genetics, Inc..

SEC CIK

Regina E Groves's CIK is 0001653877

Past Insider Trading and Trends

2017 was Regina E Groves's most active year for acquiring shares with 9 total transactions. Regina E Groves's most active month to acquire stocks was the month of April. 2021 was Regina E Groves's most active year for disposing of shares, totalling 2 transactions. Regina E Groves's most active month to dispose stocks was the month of August. 2016 saw Regina E Groves paying a total of $27,956.98 for 333,608.5 shares, this is the most they've acquired in one year. In 2021 Regina E Groves cashed out on 7,364 shares for a total of $538,613.48, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

AtriCure, Inc.

Investor
Updated May 14, 2024
Form 4
33.89%
7.79K
May 14, 2024
30.77K
Grant
May 13
Form 4
16.10%
3.19K
May 26, 2023
22.98K
Grant
May 25
Form 4
21.96%
3.56K
May 27, 2022
19.79K
Grant
May 25
Form 4
0.21%
34.00
$76.68
$2.61K
Oct 29, 2021
16.23K
Purchase
Apr 30
Form 4
-16.31%
-3.16K
$74.73
-$235.85K
Sep 17, 2021
16.19K
Sale
Sep 15
Form 4
-17.86%
-4.21K
$71.95
-$302.77K
May 28, 2021
19.35K
Sale
May 26
Form 4
8.02%
1.75K
May 24, 2021
23.56K
Grant
May 20
Form 4
-22.45%
-6.31K
$41.83
-$264.07K
Sep 16, 2020
21.81K
Sale
Sep 14
Form 4
9.55%
2.45K
May 22, 2020
28.12K
Grant
May 20
Form 4
1.99%
500.00
$24.86
$12.43K
Sep 16, 2019
25.67K
Purchase
Sep 12
Form 4
20.07%
4.21K
May 24, 2019
25.17K
Grant
May 22
Form 4
33.60%
5.27K
Jun 01, 2018
20.96K
Grant
May 31
Form 4
49.87%
5.22K
May 24, 2018
15.69K
Grant
May 22
Form 4
10.56%
1.00K
$17.43
$17.43K
Mar 01, 2018
10.47K
Purchase
Mar 01
Form 4
9.47K
Mar 23, 2017
9.47K
Grant
Mar 21
Form 3
Mar 21, 2017
Showing 16 results

REVA Medical, Inc.

Chief Executive Officer
Updated Jul 02, 2018
Form 4
4.16%
9.82K
$1.53
$15.02K
Jul 02, 2018
245.92K
Purchase
Jun 29
Form 4
278.44%
340.00K
May 18, 2018
462.11K
Grant
May 16
Form 4
0.65%
794.20
$6.37
$5.06K
Aug 30, 2017
122.11K
Purchase
Aug 23 - Aug 29
Form 4
0.59%
705.80
$5.74
$4.05K
Aug 21, 2017
121.31K
Purchase
Aug 17 - Aug 21
Form 4
96.05%
87.75K
May 22, 2017
179.11K
Grant
May 19
Form 4
7,295.28%
263.25K
Mar 22, 2017
266.86K
Grant
Mar 20
Form 4
290.11%
2.68K
$7.45
$20.00K
Jul 19, 2016
3.61K
Purchase
Jul 15
Form 4
925.00
$8.60
$7.96K
Mar 31, 2016
925.00
Purchase
Mar 30
Form 4
330.00K
Feb 18, 2016
330.00K
Grant
Feb 16
Form 4
1.67M
Sep 28, 2015
1.67M
Grant
Sep 24
Form 3
Sep 24, 2015
Showing 11 results

Fulgent Genetics, Inc.

Investor
Updated May 20, 2024
Form 4
237.03%
9.48K
May 20, 2024
13.48K
Grant
May 16
Form 4
6.76K
May 22, 2023
6.76K
Grant
May 18
Form 4
14.00K
Jan 04, 2023
14.00K
Grant
Jan 03
Form 3
Jan 04, 2023
Showing 4 results